TP53 and neoplasm: And the mechanism of synergistic anti-hepatocarcinogenesis of the two drugs may be that CUR down-regulates the expression of DPYP protein by up-regulating the expression of p53 protein, increasing the cytotoxicity of 5-FU and enhancing the anti-tumor effect.